Multinational research-based biopharmaceutical company AbbVie‘s product DUOPA is a fresh approach to the administration of carbidopa and levodopa…
Charles Moore
Charles is a force to be reckoned with in the world of print and new media. From an interview with him in LowEndMac: ”His articles, features, and commentaries have appeared in more than 40 magazines, newspapers and websites in Canada, the US, the UK, and Australia. . . a columnist for The Halifax Daily News and the Saint John Telegraph Journal, Atlantic Fisherman, and news editor and columnist for Applelinks.com, a columnist and contributing editor for MacOpinion and PBCentral, as well as writing for Low End Mac.” Charles serves as the Senior Section Editor.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Charles Moore
An unparalleled dataset capturing the everyday experiences of the more than 9,500 people enrolled in the mPower…
“The importance of clinical trials to bring effective treatments to market is critical,” says American Parkinson…
GyroGear, a medical device invention and development company currently based at Imperial College London, is developing an assistive device for…
Cynapsus Therapeutics, Inc., a Toronto-based specialty pharmaceutical company, and The Michael J. Fox Foundation for Parkinson’s Research (MJFF) announced they are…
At the first Spark Summit Europe, a presentation by Intel researchers in cooperation with the Michael J. Fox…
As part of its National Family Caregivers Month effort, the Parkinson’s Disease Foundation (PDF) a research, education and advocacy organization,…
Stable Parkinson’s Disease Drug Therapy Status Quo Could Soon Be Disrupted by New Category Entrants
Burlington, Massachusetts-based, medical market research firm Decision Resources Group (DRG) reports, citing analyses of U.S. longitudinal patient-level claims data,…
Valley View, Ohio-based Great Lakes NeuroTechnologies (GLNT) have announced receipt of a new allowance of claims from the U.S. Patent…
Pittsburgh, Pennsylvania based AbiliLife, a company dedicated to improving the quality of life for people with Parkinson’s, is raising money…